Wednesday, May 26, 2021

CMS delays controversial best price requirement for drugmakersCMS delays controversial best price requirement for drugmakersCMS delays controversial best price requirement for drugmakers

CMS delays controversial best price requirement for drugmakers

CMS delayed the Medicaid drug rebate program requirements until July 2022. Drugmakers sued the federal government over them last week.



from Section Page News - Modern Healthcare https://ift.tt/3oRnlFj

No comments:

Post a Comment